IL-6 serum levels predict postoperative morbidity in gastric cancer patients

Author： Szczepanik Antoni  

Publisher： Springer Publishing Company

ISSN： 1436-3291

Source： Gastric Cancer, Vol.14, Iss.3, 2011-08, pp. : 266-273

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Serum microRNA21 levels are related to tumor size in gastric cancer patients but cannot predict prognosis

By                  

Oncology Letters, Vol. 6, Iss. 6, 2013-01 ,pp. : 1733-1737

Spandidos Publications

Access to resources Recommend Favorite

Elevated levels of circulating platelet microparticles, VEGF, IL-6 and RANTES in patients with gastric cancer: possible role of a metastasis predictor

By Kim H.K.   Song K.S.   Park Y.S.   Kang Y.H.   Lee Y.J.   Lee K.R.   Kim H.K.   Ryu K.W.   Bae J.M.   Kim S.  

European Journal of Cancer, Vol. 39, Iss. 2, 2003-01 ,pp. : 184-191

Elsevier

Access to resources Recommend Favorite

Soluble E-cadherin and IL-6 serum levels in patients affected by prostate cancer before and after prostatectomy

By                  

Oncology Reports, Vol. 28, Iss. 1, 2012-01 ,pp. : 370-374

Spandidos Publications

Access to resources Recommend Favorite

The association of serum adiponectin levels with histopathological variables in gastric cancer patients

By Seker Mesut  

Medical Oncology, Vol. 27, Iss. 4, 2010-12 ,pp. : 1319-1323

Humana Press, Inc

Access to resources Recommend Favorite

Relationship between serum IL-18 and VEGF levels in patients with prostate cancer

By Nong Shaojun   Zhang Yueping   Zhou Shujun   Li Wenguang   Ma Limin   Wu You  

The Chinese-German Journal of Clinical Oncology, Vol. 9, Iss. 11, 2010-11 ,pp. : 643-647

Springer Publishing Company

Access to resources Recommend Favorite